GE Healthcare Grants License for Biomagnetic Isolation of Nucleic Acids to Applied Biosystems

GE Healthcare announced today that it has completed a license
agreement with Applied Biosystems, granting Applied Biosystems access
to GE Healthcare patents for the biomagnetic isolation of nucleic
acids. The license, which is valid for the lifetime of the patents,
grants Applied Biosystems certain rights with respect to the isolation
and purification of nucleic acids using GE Healthcare's proprietary
magnetic separation technology.

GE Healthcare's patented methods for magnetic separation offer
significant advantages over conventional techniques for the isolation
and purification of biomolecules such as DNA and RNA from laboratory
and clinical samples. Benefits include greater yields of product and
elimination of clogging associated with filter-based methods

"This license recognizes the considerable value that our
biomagnetic isolation technology brings to genomics researchers" said
Eric Roman, General Manager, Genomic Sciences, GE Healthcare. "We are
pleased to grant Applied Biosystems access to our patents in this
area, which will allow them to use our proprietary magnetic separation
protocols in conjunction with their MagMax(TM) range of products for
nucleic acid isolation"

GE Healthcare has an active program to grant licenses for access
to its patents for biomagnetic isolation. Financial terms were not
disclosed.

About GE Healthcare

GE Healthcare provides transformational medical technologies and
services that are shaping a new age of patient care. Our expertise in
medical imaging and information technologies, medical diagnostics,
patient monitoring systems, performance improvement, drug discovery,
and biopharmaceutical manufacturing technologies is helping clinicians
around the world re-imagine new ways to predict, diagnose, inform,
treat and monitor disease, so patients can live their lives to the
fullest.

GE Healthcare's broad range of products and services enable
healthcare providers to better diagnose and treat cancer, heart
disease, neurological diseases and other conditions earlier. Our
vision for the future is to enable a new "early health" model of care
focused on earlier diagnosis, pre-symptomatic disease detection and
disease prevention. Headquartered in the United Kingdom, GE Healthcare
is a $17 billion unit of General Electric Company (NYSE: GE).
Worldwide, GE Healthcare employs more than 46,000 people committed to
serving healthcare professionals and their patients in more than 100
countries. For more information about GE Healthcare, visit our website
at www.gehealthcare.com.